{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:59:49Z","timestamp":1753891189723,"version":"3.41.2"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Nodal T-follicular helper cell lymphomas (nTFHLs) represent a new family of peripheral T-cell lymphomas (PTCLs), and comparative studies of their constituents are rare.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study retrospectively enrolled 10 patients with nTFHL-F and 30 patients with nTFHL-NOS diagnosed between December 2017 and October 2023 at six large comprehensive tertiary hospitals; 188 patients with nTFHL-AI were diagnosed during the same period at the First Affiliated Hospital of Zhengzhou University for comparison.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared with nTFHL-AI, nTFHL-NOS patients exhibited better clinical manifestations, lower TFH expression levels, and a lower Ki-67 index. However, no differences in clinicopathological features were observed between nTFHL-F and nTFHL-AI patients as well as nTFHL-NOS patients. According to the survival analysis, the median OS for patients with nTFHL-NOS, nTFHL-AI, and nTFHL-F were 14.2 months, 10 months, and 5 months, respectively, whereas the median TTP were 14 months, 5 months, and 3 months, respectively. Statistical analysis revealed differences in TTP among the three subtypes(<jats:italic>P<\/jats:italic>=0.0173). Among the population of patients receiving CHOP-like induction therapy, there were significant differences in the OS and TTP among the nTFHL-NOS, nTFHL-AI, and nTFHL-F patients (<jats:italic>P<\/jats:italic>=0.0134, <jats:italic>P<\/jats:italic>=0.0205). Both the GDPT and C-PET regimens significantly improved the ORR, OS, and PFS in nTFHL patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>There are significant differences in the clinical manifestations, pathology, and survival outcomes among the three subtypes of nTFHLs. However, further research with a larger sample size, and involving clinical pathology and molecular genetics is needed to determine the distinctive biological characteristics of these tumors.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1371534","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T05:07:31Z","timestamp":1711516051000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinicopathologic analysis of nodal T-follicular helper cell lymphomas, a multicenter retrospective study from China"],"prefix":"10.3389","volume":"15","author":[{"given":"Shanshan","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaona","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wencai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Sang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T follicular helper cell biology: A decade of discovery and diseases","volume":"50","author":"Crotty","year":"2019","journal-title":"Immunity"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-02-698977","article-title":"Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas","volume":"128","author":"Vallois","year":"2016","journal-title":"Blood."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.158428","article-title":"Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin","volume":"102","author":"Dobay","year":"2017","journal-title":"Haematologica."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-408542","article-title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters","volume":"120","author":"Lemonnier","year":"2012","journal-title":"Blood."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-05-644591","article-title":"IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma","volume":"126","author":"Wang","year":"2015","journal-title":"Blood."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0473-1","article-title":"Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling","volume":"33","author":"Watatani","year":"2019","journal-title":"Leukemia."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-023-03607-5","article-title":"Follicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics","volume":"483","author":"Ondrejka","year":"2023","journal-title":"A Rep 2022 EA4HP\/SH lymphoma workshop. Virchows Arch"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1105651","article-title":"Pathologic and molecular insights in nodal T-follicular helper cell lymphomas","volume":"13","author":"Marques-Piubelli","year":"2023","journal-title":"Front Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia."},{"key":"B14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.14735\/amko2016295","article-title":"[Staging and treatment response evaluation in Malignant lymphomas - czech lymphoma study group recommendations according to criteria revised in 2014 (Lugano classification)]","volume":"29","author":"Sykorova","year":"2016","journal-title":"Klin Onkol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40164-021-00224-3","article-title":"Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas","volume":"10","author":"Yoon","year":"2021","journal-title":"Exp Hematol Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18941","article-title":"Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study","volume":"203","author":"Martin Garcia-Sancho","year":"2023","journal-title":"Br J Haematol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1177\/03008916211027219","article-title":"Duvelisib as bridge to allotransplantation in refractory peripheral T-cell lymphoma with T-follicular helper phenotype: case report","volume":"107","author":"Lolli","year":"2021","journal-title":"Tumori."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.7180-21","article-title":"Nodal peripheral T-cell lymphoma with T follicular helper phenotype presenting as chorea during treatment: A case report and literature review","volume":"60","author":"Kitamura","year":"2021","journal-title":"Intern Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3960\/jslrt.22038","article-title":"Benefit of prednisolone alone in nodal peripheral T-cell lymphoma with T follicular helper phenotype","volume":"63","author":"Kitamura","year":"2023","journal-title":"J Clin Exp Hematop."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2018.03.024","article-title":"Cryoglobulinemic glomerulonephritis associated with nodal and renal infiltration by T-cell lymphoma of T-follicular helper phenotype: A case report","volume":"72","author":"Li","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0253-2727.2023.07.013","article-title":"Dual epigenetic therapy in TET2 gene positive extranodal peripheral T-cell lymphoma with follicular helper T-cell (TFH) phenotype: a case report and literature review","volume":"44","author":"Lang","year":"2023","journal-title":"Zhonghua Xue Ye Xue Za Zhi."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-022-04805-y","article-title":"Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma","volume":"101","author":"Lee","year":"2022","journal-title":"Ann Hematol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.3390\/cancers14102392","article-title":"Novel T follicular helper-like T-cell lymphoma therapies: from preclinical evaluation to clinical reality","volume":"14","author":"Krug","year":"2022","journal-title":"Cancers (Basel)."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1163190","article-title":"Precise diagnosis and targeted therapy of nodal T-follicular helper cell lymphoma (T-FHCL)","volume":"13","author":"Du","year":"2023","journal-title":"Front Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26499","article-title":"Chidamide plus prednisone, etoposide, and thalidomide for untreated angioimmunoblastic T-cell lymphoma in a Chinese population: A multicenter phase II trial","volume":"97","author":"Wang","year":"2022","journal-title":"Am J Hematol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920923829","article-title":"Outcomes of GDPT (gemcitabine, cisplatin, prednisone, thalidomide) versus CHOP in newly diagnosed peripheral T-cell lymphoma patients","volume":"12","author":"Sun","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-021-03071-z","article-title":"Clinicopathological characterization of follicular helper T-cell-derived peripheral T-cell lymphoma involving Waldeyer's ring","volume":"479","author":"Wang","year":"2021","journal-title":"Virchows Arch"},{"key":"B28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/hon.2593","article-title":"15th International Conference on Malignant Lymphoma Palazzo dei Congressi, Lugano, Switzerland","year":"2019","journal-title":"Hematol Oncol"},{"key":"B29","article-title":"Update on recurrent mutations in angioimmunoblastic T-cell lymphoma","volume":"14","author":"Yu","year":"2021","journal-title":"Int J Clin Exp Pathol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ccell.2023.01.003","article-title":"IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment","volume":"41","author":"Leca","year":"2023","journal-title":"Cancer Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2012.05.002","article-title":"Follicular T-cell lymphoma: a member of an emerging family of follicular helper T-cell derived T-cell lymphomas","volume":"43","author":"Hu","year":"2012","journal-title":"Hum Pathol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20092042","article-title":"The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma","volume":"207","author":"Pechloff","year":"2010","journal-title":"J Exp Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1371534\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T05:08:35Z","timestamp":1711516115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1371534\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,27]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2024.1371534"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1371534","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2024,3,27]]},"article-number":"1371534"}}